Revision and update on clinical practice guideline for liver cirrhosis

259 706

Cited 0 times in

Authors: Ki Tae Suk ; Soon Koo Baik ; Jung Hwan Yoon ; Jae Youn Cheong ; Yong Han Paik ; Chang Hyeong Lee ; Young Seok Kim ; Jin Woo Lee ; Dong Joon Kim ; Sung Won Cho ; Seong Gyu Hwang ; Joo Hyun Sohn ; Moon Young Kim ; Young Bae Kim ; Jae Geun Kim ; Yong Kyun Cho ; Moon Seok Choi ; Hyung Joon Kim ; Hyun Woong Lee ; Seung Up Kim ; Ja Kyung Kim ; Jin Young Choi ; Dae Won Jun ; Won Young Tak ; Byung Seok Lee ; Byoung Kuk Jang ; Woo Jin Chung ; Hong Soo Kim ; Jae Young Jang ; Soung Won Jeong ; Sang Gyune Kim ; Oh Sang Kwon ; Young Kul Jung ; Won Hyeok Choe ; June Sung Lee ; In Hee Kim ; Jae Jun Shim ; Gab Jin Cheon ; Si Hyun Bae ; Yeon Seok Seo ; Dae Hee Choi ; Se Jin Jang

MeSH: Antiviral Agents/therapeutic use ; Ascites/diagnosis ; Ascites/prevention & control ; Ascites/therapy ; Cholagogues and Choleretics/therapeutic use ; Fatty Liver/diagnosis ; Fatty Liver/diet therapy ; Fatty Liver, Alcoholic/diagnosis ; Fatty Liver, Alcoholic/drug therapy ; Hemorrhage/prevention & control ; Hemorrhage/therapy ; Hepatic Encephalopathy/diagnosis ; Hepatic Encephalopathy/prevention & control ; Hepatic Encephalopathy/therapy ; Hepatitis B, Chronic/diagnosis ; Hepatitis B, Chronic/drug therapy ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/drug therapy ; Humans ; Liver Cirrhosis/diagnosis* ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/pathology ; Liver Cirrhosis/therapy* ; Liver Cirrhosis, Biliary/drug therapy ; Non-alcoholic Fatty Liver Disease ; Vasodilator Agents/therapeutic use